content

IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology

IDEAYA Biosciences, Inc. and GlaxoSmithKline plc announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology. The strategic partnership includes IDEAYAโ€™s Synthetic Lethality...

Pfizer Announced FDA Approval of Oncology Supportive Care Biosimilar, NYVEPRIA

Pfizer Inc. announced the US FDA has approved NYVEPRIA, a biosimilar to Neulasta NYVEPRIA is indicated to decrease the incidence of infection, as manifested...

Sunovion Announces Health Canada Approval of KYNMOBI Soluble Film for the Treatment of Parkinson’s Disease OFF Episodes

Sunovion Pharmaceuticals Inc. announced that Health Canada has approved KYNMOBI soluble film for the acute, intermittent treatment of OFF episodes in patients with Parkinsonโ€™s...

Dr. Reddys Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir

Dr. Reddy's Laboratories Ltd announced that it has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. (Gilead)that will grant Dr. Reddyโ€™s the...

Biocon and Mylan get U.S. FDA approval for insulin glargine injection

Mylan N.V. and Biocon Ltd. announced that the U.S. FDA has approved the New Drug Application (NDA) for Semglee (insulin glargine injection), in vial...

AstraZeneca to Supply Europe with 400M Doses of COVID-19 Vaccine

AstraZeneca has reached an agreement with Europeโ€™s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400...

Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate

Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read